IVD Wiki from Genrui
Genrui is pleased to announce that selected Specific Protein assays used on the PA240 and PA480 Fully Automated Specific Protein Analyzers have successfully completed the 2026 External Quality Assessm...
Read More >WHX Labs Dubai 2026, one of the most influential and large-scale exhibitions for medical laboratory equipment and supplies in the Middle East.Genrui proudly showcased its presence at this prestigious ...
Read More >From November 17th to 20th, MEDICA—the world’s largest and most influential event in the medical industry—was successfully held in Düsseldorf, Germany. Renowned for its professionalism, scale, and...
Read More >Genrui is pleased to announce that selected Specific Protein assays used on the PA240 and PA480 Fully Automated Specific Protein Analyzers have successfully completed the 2026 External Quality Assessm...
WHX Labs Dubai 2026, one of the most influential and large-scale exhibitions for medical laboratory equipment and supplies in the Middle East.Genrui proudly showcased its presence at this prestigious ...
From November 17th to 20th, MEDICA—the world’s largest and most influential event in the medical industry—was successfully held in Düsseldorf, Germany. Renowned for its professionalism, scale, and...
Who We Are
Genrui Biotech Inc. is a leading Chinese in vitro diagnostics (IVD) medical device company dedicated to the development, manufacturing, and marketing of IVD instruments, reagents, and comprehensive solutions. Founded in 2004, Genrui has achieved strong growth in both product innovation and global market presence. The company's portfolio spans hematology, specific protein, point-of-care testing (POCT), chemistry, and chemiluminescence, together with their associated reagents. Genrui's products have been widely adopted across China and are now exported to more than 120 countries, earning the company solid respect and recognition throughout the industry.
As a national high-tech enterprise certified to ISO 13485 and ISO 9001, Genrui upholds high standards across every aspect of its operations — from product development, manufacturing, and quality control to customer relations.
20+ Years
Established in 2004, Genrui has devoted over 20 years to in-vitro diagnostics, earning the lasting trust of partners worldwide through continuous innovation.
500+ employees
Genrui has over 500 employees and over 28% of them are in the R&D department.
R&D
Genrui invests 10%-20% of turnover in R&D, securing 3-8 yearly new product launches.
Over 120 countries
Our products have been exported to over 120 countries, quality has been recognized by a lot of countries around the world.
Mission & Vision
Mission
Provide professional IVD solutions to customers over the world.
Vision
To be an outstanding IVD supplier with a global presence.
Core Value
Grow and share.
Genrui is pleased to announce that selected Specific Protein assays used on the PA240 and PA480 Fully Automated Specific Protein Analyzers have successfully completed the 2026 External Quality Assessm...
WHX Labs Dubai 2026, one of the most influential and large-scale exhibitions for medical laboratory equipment and supplies in the Middle East.Genrui proudly showcased its presence at this prestigious ...
From November 17th to 20th, MEDICA—the world’s largest and most influential event in the medical industry—was successfully held in Düsseldorf, Germany. Renowned for its professionalism, scale, and...